Redmile Group Sells 3.1M ADC Therapeutics Shares at $3.28/Share on April 2, 2026.

ADC Therapeutics SA (ADCT) has announced that Redmile Group, LLC, a 10% owner of the company, has executed multiple share sales. Specifically, Redmile Group has sold 2,634,506 shares at $3.28 per share on April 2, 2026, and another 2,529,491 shares at the same price on the same day. Additionally, the company has sold 169,265 shares at $3.80 per share on April 1, 2026, as well as 196,229 shares at $3.75 per share on March 31, 2026. Furthermore, Redmile Group has sold 162,517 shares at $3.80 per share on April 1, 2026, and 188,407 shares at $3.75 per share on March 31, 2026. These transactions were executed in accordance with applicable securities laws and regulations.